A Double-Blind, Randomized, Placebo-controlled, Phase 1 Dose Escalation Trial to Evaluate the Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine, HydroVax-001, in Healthy Adults

Administered By

Awarded By

Contributors

Start/End

  • November 10, 2014 - February 28, 2018